Patients must NOT have radiotherapy, or major surgery or active drug therapy for pNET (SSA permitted) within 4 weeks prior to study treatment start
Patients must have completed any major surgery or open biopsy >= 4 weeks from start of treatment
Recovered from any previous surgery and no history of major surgery within the last 28 days prior to start of study drug
Major surgery within 4 weeks of study treatment start
Major surgery within 28 days before the start of trial treatment (excluding prior diagnostic biopsy); or use of any investigational drug within 28 days before the start of trial treatment.
Major surgery within 3 weeks prior to the start of study treatment
Major surgery within 4 weeks before the start of study therapy.
Major surgery within 4 weeks before the start of study therapy.
Major surgery as determined by the investigator within 28 days before the start of trial treatment (prior diagnostic biopsy is permitted).
Major surgery as determined by the investigator within 28 days before the start of trial treatment (prior diagnostic biopsy is permitted).
Major surgery within 4 weeks before the start of study therapy.
Major surgery within 4 weeks before the start of study therapy.
Recent major surgery (within 6 weeks prior to the start of study treatment) other than for diagnosis
At least 3 weeks between major surgery and planned start of study treatment; major incisions must have healed
Subjects must start study agent within 6 weeks from the first diagnostic surgery for glioblastoma
No major surgery within 14 days of start of study treatment
Major surgery (within 4 weeks prior to the start of cycle 1), other than for diagnosis
Recent major surgery (within 4 weeks prior to the start of Cycle 1), other than for diagnosis
Recent major surgery (within 6 weeks prior to the start of study treatment) other than for diagnosis
Major surgery within 30 days prior to the start of study medication.
Major surgery within 30 days prior to start of treatment
Any treatment modalities involving major surgery within 4 weeks prior to the start of study treatment
Major surgery within 14 days prior to start of study treatment
Major surgery (within 4 weeks prior to the start of cycle 1), except for procedures that are performed for diagnostic purposes
Major surgery within 3 weeks of the start of study treatment, without complete recovery
Major surgery within 2 weeks of the start of study treatment, or ongoing complications from surgeries performed previously
A minimum of 4 weeks from any major surgery prior to start of study drug
Patients must not have any major surgery or radiation therapy within 14 days of start of study treatment
Major surgery within 4 weeks or minor surgery within 2 weeks of the start of study drug.
Major surgery within 14 days prior to start of study treatment
Subjects who have had a major surgery or significant trauma within 4 weeks before the start of study treatment
Patients who have had major surgery without full recovery or major surgery within three weeks of the start of vaccine treatment
Major surgery less than 1 month before start of the study
Major surgery less than 1 month before the start of the study
Had a major surgery or significant trauma within 4 weeks before the start of anetumab ravtansine
Major surgery performed < 28 days from treatment start
Major surgery within 28 days before the start of trial treatment (prior diagnostic biopsy is permitted)
Major surgery, excluding laparoscopy, within 4 weeks of the start of study treatment, without complete recovery
Major surgery within 4 weeks of the start of study treatment, without complete recovery
Major surgery (within 4 weeks prior to the start of cycle 1), other than for diagnosis
Major surgery within 30 days prior to start of study drug
Major surgery (within 4 weeks prior to the start of cycle 1), except for procedures that are performed for diagnostic purposes
Major surgery within 30 days prior to start of study drug
Prior major surgery less than 4 weeks prior to the start of the study;
A minimum of 4 weeks from any major surgery prior to start of study drug
Major surgery within 30 days prior to start of study drug
Major surgery, excluding laparoscopy, within 4 weeks of the start of study treatment, without complete recovery
Major surgery < 4 weeks from the start of treatment
Patients with major surgery less than 3 months prior to start study drug or who have still side effects of such therapy.
Major surgery, excluding laparoscopy, within 4 weeks of the start of study treatment, without complete recovery
Patients who have received any cytotoxic therapy, immunotherapy, antitumor vaccines, monoclonal antibodies or major surgery in the 4 weeks prior to the start of the study
Major surgery, excluding laparoscopy, within 4 weeks of the start of study treatment, without complete recovery
Recent major surgery (within 4 weeks prior to start of Cycle 1), other than for diagnosis
Major or minor surgery < 28 and <14 days from the start of treatment, respectively;
Major surgery within 4 weeks before the start of study therapy.
Major surgery within 4 weeks before the start of study therapy;
Major surgery or anti-cancer therapy within 4 weeks of study treatment start.
Major surgery within 4 weeks of the start of study treatment, without complete recovery
Major surgery, excluding laparoscopy, within 4 weeks of the start of study treatment, without complete recovery
Less than 3 weeks between major surgery and planned start of study treatment; major incisions must have healed
Major surgery (within 4 weeks prior to the start of Cycle 1), other than for diagnosis
Major surgery within 4 weeks before start of study treatment, without complete recovery
Major surgery within 4 weeks of the start of study treatment, without complete recovery
Major injuries and/or surgery within the past ten days prior to start of study drug
Major surgery within 4 weeks prior to the start of the study;
Major surgery or radiation therapy within 4 weeks from start of treatment
Major surgery less than 4 weeks before the start of the study
Major surgery within 14 days prior to start of study treatment
Major surgery within 4 weeks of the start of study treatment, without complete recovery
